Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent

Genetic or pharmacological ablation of toll-like receptor 2 (TLR2) protects against myocardial ischemia/reperfusion injury (MI/R). However, the endogenous ligand responsible for TLR2 activation has not yet been detected. The objective of this study was to identify HMGB1 as an activator of TLR2 signa...

Full description

Saved in:
Bibliographic Details
Main Authors: Jan Mersmann, Franziska Iskandar, Kathrina Latsch, Katharina Habeck, Vera Sprunck, René Zimmermann, Ralf R. Schumann, Kai Zacharowski, Alexander Koch
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/174168
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559422966071296
author Jan Mersmann
Franziska Iskandar
Kathrina Latsch
Katharina Habeck
Vera Sprunck
René Zimmermann
Ralf R. Schumann
Kai Zacharowski
Alexander Koch
author_facet Jan Mersmann
Franziska Iskandar
Kathrina Latsch
Katharina Habeck
Vera Sprunck
René Zimmermann
Ralf R. Schumann
Kai Zacharowski
Alexander Koch
author_sort Jan Mersmann
collection DOAJ
description Genetic or pharmacological ablation of toll-like receptor 2 (TLR2) protects against myocardial ischemia/reperfusion injury (MI/R). However, the endogenous ligand responsible for TLR2 activation has not yet been detected. The objective of this study was to identify HMGB1 as an activator of TLR2 signalling during MI/R. C57BL/6 wild-type (WT) or TLR2−/−-mice were injected with vehicle, HMGB1, or HMGB1 BoxA one hour before myocardial ischemia (30 min) and reperfusion (24 hrs). Infarct size, cardiac troponin T, leukocyte infiltration, HMGB1 release, TLR4-, TLR9-, and RAGE-expression were quantified. HMGB1 plasma levels were measured in patients undergoing coronary artery bypass graft (CABG) surgery. HMGB1 antagonist BoxA reduced cardiomyocyte necrosis during MI/R in WT mice, accompanied by reduced leukocyte infiltration. Injection of HMGB1 did, however, not increase infarct size in WT animals. In TLR2−/−-hearts, neither BoxA nor HMGB1 affected infarct size. No differences in RAGE and TLR9 expression could be detected, while TLR2−/−-mice display increased TLR4 and HMGB1 expression. Plasma levels of HMGB1 were increased MI/R in TLR2−/−-mice after CABG surgery in patients carrying a TLR2 polymorphism (Arg753Gln). We here provide evidence that absence of TLR2 signalling abrogates infarct-sparing effects of HMGB1 blockade.
format Article
id doaj-art-767ef945db1549ab82aa7df514de922f
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-767ef945db1549ab82aa7df514de922f2025-02-03T01:30:08ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/174168174168Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-DependentJan Mersmann0Franziska Iskandar1Kathrina Latsch2Katharina Habeck3Vera Sprunck4René Zimmermann5Ralf R. Schumann6Kai Zacharowski7Alexander Koch8Department of Anaesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, GermanyDepartment of Anaesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, GermanyDepartment of Anaesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, GermanyDepartment of Anaesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, GermanyDepartment of Anaesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, GermanyDepartment of Anaesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, GermanyInstitute for Microbiology and Hygiene, Charité Medical Center, 12203 Berlin, GermanyDepartment of Anaesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, GermanyDepartment of Anaesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, GermanyGenetic or pharmacological ablation of toll-like receptor 2 (TLR2) protects against myocardial ischemia/reperfusion injury (MI/R). However, the endogenous ligand responsible for TLR2 activation has not yet been detected. The objective of this study was to identify HMGB1 as an activator of TLR2 signalling during MI/R. C57BL/6 wild-type (WT) or TLR2−/−-mice were injected with vehicle, HMGB1, or HMGB1 BoxA one hour before myocardial ischemia (30 min) and reperfusion (24 hrs). Infarct size, cardiac troponin T, leukocyte infiltration, HMGB1 release, TLR4-, TLR9-, and RAGE-expression were quantified. HMGB1 plasma levels were measured in patients undergoing coronary artery bypass graft (CABG) surgery. HMGB1 antagonist BoxA reduced cardiomyocyte necrosis during MI/R in WT mice, accompanied by reduced leukocyte infiltration. Injection of HMGB1 did, however, not increase infarct size in WT animals. In TLR2−/−-hearts, neither BoxA nor HMGB1 affected infarct size. No differences in RAGE and TLR9 expression could be detected, while TLR2−/−-mice display increased TLR4 and HMGB1 expression. Plasma levels of HMGB1 were increased MI/R in TLR2−/−-mice after CABG surgery in patients carrying a TLR2 polymorphism (Arg753Gln). We here provide evidence that absence of TLR2 signalling abrogates infarct-sparing effects of HMGB1 blockade.http://dx.doi.org/10.1155/2013/174168
spellingShingle Jan Mersmann
Franziska Iskandar
Kathrina Latsch
Katharina Habeck
Vera Sprunck
René Zimmermann
Ralf R. Schumann
Kai Zacharowski
Alexander Koch
Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent
Mediators of Inflammation
title Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent
title_full Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent
title_fullStr Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent
title_full_unstemmed Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent
title_short Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent
title_sort attenuation of myocardial injury by hmgb1 blockade during ischemia reperfusion is toll like receptor 2 dependent
url http://dx.doi.org/10.1155/2013/174168
work_keys_str_mv AT janmersmann attenuationofmyocardialinjurybyhmgb1blockadeduringischemiareperfusionistolllikereceptor2dependent
AT franziskaiskandar attenuationofmyocardialinjurybyhmgb1blockadeduringischemiareperfusionistolllikereceptor2dependent
AT kathrinalatsch attenuationofmyocardialinjurybyhmgb1blockadeduringischemiareperfusionistolllikereceptor2dependent
AT katharinahabeck attenuationofmyocardialinjurybyhmgb1blockadeduringischemiareperfusionistolllikereceptor2dependent
AT verasprunck attenuationofmyocardialinjurybyhmgb1blockadeduringischemiareperfusionistolllikereceptor2dependent
AT renezimmermann attenuationofmyocardialinjurybyhmgb1blockadeduringischemiareperfusionistolllikereceptor2dependent
AT ralfrschumann attenuationofmyocardialinjurybyhmgb1blockadeduringischemiareperfusionistolllikereceptor2dependent
AT kaizacharowski attenuationofmyocardialinjurybyhmgb1blockadeduringischemiareperfusionistolllikereceptor2dependent
AT alexanderkoch attenuationofmyocardialinjurybyhmgb1blockadeduringischemiareperfusionistolllikereceptor2dependent